Tivic Reports Full Year 2025 Results

Completes Strategic Transformation into an Immunotherapy Company and Continues to Advance Entolimod Platform Toward Potential Funding PartnershipsConference Call to be Held Today at 1:30 PM PT / 4:30 PM ET SAN ANTONIO, TX / ACCESS Newswire / March 25, 2026 / Tivic...

Tivic Health CEO Letter to Shareholders

SAN ANTONIO, TX / ACCESS Newswire / March 24, 2026 / Tivic Health Systems (Nasdaq:TIVC)Dear Valued Shareholders,As I assume the role of Chief Executive Officer at Tivic, my immediate priority is to establish a transparent dialogue with you regarding our current...